PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.730
-0.040 (-0.84%)
At close: Aug 11, 2026, 4:00 PM EDT
4.720
-0.010 (-0.21%)
After-hours: Aug 11, 2026, 6:34 PM EDT
PolyPid Employees
As of December 31, 2025, PolyPid had 75 total employees, including 69 full-time and 6 part-time employees. The number of employees increased by 14 or 22.95% compared to the previous year.
Employees
75
Change (1Y)
14
Growth (1Y)
22.95%
Revenue / Employee
n/a
Profits / Employee
-$448,387
Market Cap
90.69M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 75 | 14 | 22.95% | 69 | 6 |
| Dec 31, 2024 | 61 | -1 | -1.61% | 57 | 4 |
| Dec 31, 2023 | 62 | 2 | 3.33% | 59 | 3 |
| Dec 31, 2022 | 60 | -19 | -24.05% | 57 | 3 |
| Dec 31, 2021 | 79 | 10 | 14.49% | 75 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| Inovio Pharmaceuticals | 112 |
| Adicet Bio | 102 |
| Fortress Biotech | 78 |
| Verrica Pharmaceuticals | 76 |
| Biomea Fusion | 37 |
| Tenax Therapeutics | 16 |
| Cognition Therapeutics | 14 |
PYPD News
- 12 days ago - PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026 - GlobeNewsWire
- 13 days ago - PolyPid NDA acceptance ‘meets or exceeds’ expectations, says Roth Capital - TheFly
- 13 days ago - PolyPid announces FDA acceptance of, priority review for D-PLEX100 - TheFly
- 13 days ago - PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀ - GlobeNewsWire
- 20 days ago - PolyPid price target lowered to $12 from $13 at Craig-Hallum - TheFly
- 21 days ago - Roth says Azurity deal validates D-PLEX100, sees limited near-term revenue - TheFly
- 21 days ago - PolyPid Stock (PYPD) Plummets Despite Deal With Azurity to Tackle Surgical Infections - TipRanks
- 21 days ago - PolyPid enters exclusive pact with Azurity Pharmaceuticals for D-PLEX100 - TheFly